Carmona S - Search Results

1

Site-directed mutagenesis by fusion of contiguous DNA fragments.

Carmona S, Passman M, Kew M, Arbuthnot P. Carmona S, et al. Biotechniques. 1999 Mar;26(3):382-4, 386. doi: 10.2144/99263bm02. Biotechniques. 1999. PMID: 10090968 Free article. No abstract available.

2

Hepatitis B virus X-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation.

Capovilla A, Carmona S, Arbuthnot P. Capovilla A, et al. Among authors: carmona s. Biochem Biophys Res Commun. 1997 Mar 6;232(1):255-60. doi: 10.1006/bbrc.1997.6269. Biochem Biophys Res Commun. 1997. PMID: 9125143

3

Simplified ELISA for detecting antibodies to recombinant fusion proteins.

Carmona S, Prinz W, Arbuthnot P. Carmona S, et al. Biotechniques. 1997 Oct;23(4):627-30. doi: 10.2144/97234bm15. Biotechniques. 1997. PMID: 9343677 Free article. No abstract available.

4

Exploiting the RNA interference pathway to counter hepatitis B virus replication.

Arbuthnot P, Carmona S, Ely A. Arbuthnot P, et al. Among authors: carmona s. Liver Int. 2005 Feb;25(1):9-15. doi: 10.1111/j.1478-3231.2004.0966.x. Liver Int. 2005. PMID: 15698393 Review.

5

Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs.

Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL, Ferry N, Weinberg MS, Arbuthnot P. Carmona S, et al. Mol Ther. 2006 Feb;13(2):411-21. doi: 10.1016/j.ymthe.2005.10.013. Epub 2005 Dec 5. Mol Ther. 2006. PMID: 16337206 Free article.

6

Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag.

Cave E, Weinberg MS, Cilliers T, Carmona S, Morris L, Arbuthnot P. Cave E, et al. Among authors: carmona s. AIDS Res Hum Retroviruses. 2006 May;22(5):401-10. doi: 10.1089/aid.2006.22.401. AIDS Res Hum Retroviruses. 2006. PMID: 16706616

7

Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA.

Weinberg MS, Ely A, Barichievy S, Crowther C, Mufamadi S, Carmona S, Arbuthnot P. Weinberg MS, et al. Among authors: carmona s. Mol Ther. 2007 Mar;15(3):534-41. doi: 10.1038/sj.mt.6300077. Epub 2007 Jan 9. Mol Ther. 2007. PMID: 17213835 Free article.

8

Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.

Carmona S, Jorgensen MR, Kolli S, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Miller AD. Carmona S, et al. Mol Pharm. 2009 May-Jun;6(3):706-17. doi: 10.1021/mp800157x. Mol Pharm. 2009. PMID: 19159285

9

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Mével M, Kamaly N, Carmona S, Oliver MH, Jorgensen MR, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Yaouanc JJ, Jaffrès PA, Miller AD. Mével M, et al. Among authors: carmona s. J Control Release. 2010 Apr 19;143(2):222-32. doi: 10.1016/j.jconrel.2009.12.001. Epub 2009 Dec 5. J Control Release. 2010. PMID: 19969034

10

HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.

Steegen K, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, Variava E, MacLeod W, Sanne I, Stevens WS, Carmona S. Steegen K, et al. Among authors: carmona s. J Antimicrob Chemother. 2017 Jan;72(1):210-219. doi: 10.1093/jac/dkw358. Epub 2016 Sep 22. J Antimicrob Chemother. 2017. PMID: 27659733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters